| Name | Title | Contact Details |
|---|
At Indi we believe that a systems-based approach is necessary to understand complex diseases and improve health. Our mission is to dramatically improve diagnosis and management of complex diseases by building advanced molecular diagnostics and creating new diagnostic technologies. We seek to understand the complex biological systems from which diseases arise so that we can determine which combinations of biomarkers have the greatest diagnostic power. Then we build assays capable of measuring hundreds of proteins at a time, for more precise detection and management of disease. Our end goal is to create large-scale systems medicine diagnostics that can gather a wealth of information – and then make sense of that information so that physicians can better diagnose disease.
BioSci Research Canada Ltd is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Immunization for Public Health (i4ph) is a Galveston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.
ION Medical is a Mission Viejo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.